Juan A Moreno
Overview
Explore the profile of Juan A Moreno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
726
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Moreno J, Gonzalez-Cutre D, Martin-Albo J, Cervello E
J Sports Sci Med
. 2013 Oct;
9(1):79-85.
PMID: 24149389
The purpose of this study was to analyse, experimentally, the relationships between motivation and performance in a lateral movement test in physical education. The study group consisted of 363 students...
12.
Almagro B, Saenz-Lopez P, Moreno J
J Sports Sci Med
. 2013 Oct;
9(1):8-14.
PMID: 24149380
The purpose of this study was to test a motivational model of the coach-athlete relationship, based on self-determination theory and on the hierarchical model of intrinsic and extrinsic motivation. The...
13.
Valdivielso J, Coll B, Martin-Ventura J, Moreno J, Egido J, Fernandez E, et al.
J Nephrol
. 2013 Mar;
26(6):1105-13.
PMID: 23475462
Background: Chronic kidney disease (CKD) is characterized by a high mortality rate, primarily due to cardiovascular disease. Reduced soluble TNF-like weak inducer of apoptosis (sTWEAK) levels have been related with...
14.
Moreno J, Sastre C, Madrigal-Matute J, Munoz-Garcia B, Ortega L, Burkly L, et al.
Arterioscler Thromb Vasc Biol
. 2013 Jan;
33(3):612-20.
PMID: 23288170
Objective: High-mobility group box 1 (HMGB1), a DNA-binding cytokine expressed mainly by macrophages, contributes to lesion progression and chronic inflammation within atherosclerotic plaque. It has been suggested that different cytokines...
15.
Izquierdo M, Sanz A, Sanchez-Nino M, Perez-Gomez M, Ruiz-Ortega M, Poveda J, et al.
Nefrologia
. 2012 Oct;
32(6):715-23.
PMID: 23093094
There are no pathophysiolgical therapeutic approaches to acute kidney injury (AKI) and the mortality remains high. In addition chronic kidney disease (CKD) predisposes to AKI and AKI contributes to progression...
16.
Urbonaviciene G, Martin-Ventura J, Lindholt J, Urbonavicius S, Moreno J, Egido J, et al.
Atherosclerosis
. 2011 Oct;
219(2):892-9.
PMID: 21962403
Aim: Soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) has recently been introduced as a potential mediator of cardiovascular disease. We examined the associations between sTWEAK, its scavenger receptor...
17.
Moreno J, Izquierdo M, Sanchez-Nino M, Suarez-Alvarez B, Lopez-Larrea C, Jakubowski A, et al.
J Am Soc Nephrol
. 2011 Jul;
22(7):1315-25.
PMID: 21719790
Proinflammatory cytokines contribute to renal injury, but the downstream effectors within kidney cells are not well understood. One candidate effector is Klotho, a protein expressed by renal cells that has...
18.
Blanco-Colio L, Martin-Ventura J, Carrero J, Yilmaz M, Moreno J, Gomez-Guerrero C, et al.
Proteomics Clin Appl
. 2011 May;
5(5-6):281-8.
PMID: 21538911
In the last years, big efforts are devoted to the search of novel biomarkers. Proteomic approaches in healthy and pathological samples may help us to discern differential protein expression patterns....
19.
Munoz-Garcia B, Madrigal-Matute J, Moreno J, Martin-Ventura J, Lopez-Franco O, Sastre C, et al.
Cardiovasc Res
. 2010 Sep;
89(1):225-33.
PMID: 20810696
Aims: atherosclerotic plaque development can conclude with a thrombotic acute event triggered by plaque rupture/erosion. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) is a member of the tumour necrosis...
20.
Moreno J, Dejouvencel T, Labreuche J, Smadja D, Dussiot M, Martin-Ventura J, et al.
Arterioscler Thromb Vasc Biol
. 2010 Mar;
30(6):1253-62.
PMID: 20299688
Objective: In addition to its role in the clearance of haptoglobin-hemoglobin (Hp-Hb) complexes, CD163 is a macrophage scavenger receptor for tumor necrosis factor-like weak inducer of apoptosis (TWEAK). We recently...